HJ
Hiral Jitendrabhai Lakhani
About Hiral Jitendrabhai Lakhani
Data last updated:
Hiral Jitendrabhai Lakhani is a Director at Nilrise Pharmaceuticals Private Limited (since 2014), Director at Crinova Healthcare Private Limited (since 2019) and Director at Irenic Capitals Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Financial Services and Home & Lifestyle. The 4 current companies with reported revenue have a combined latest revenue of ₹19.04 Cr; the largest is Nilrise Pharmaceuticals Private Limited at ₹10.92 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nilrise Pharmaceuticals Private Limited U51101GJ2014PTC078226 | Director | 09 Jan 2014 | 2014 | ₹10.92 Cr (FY 2025) | Active |
 Crinova Healthcare Private Limited U51909GJ2019PTC107891 | Director | 30 Apr 2019 | 2019 | ₹7.29 Cr (FY 2025) | Active |
 Irenic Capitals Private Limited U65990GJ2022PTC129614 | Director | 23 Feb 2022 | 2022 | ₹78.5 Lakh (FY 2025) | Active |
| Opurik Innovation Private Limited U72900GJ2022PTC135713 | Director | 04 Jul 2024 | 2022 | ₹4.7 Lakh (FY 2025) | Active |
Board colleagues of Hiral Jitendrabhai Lakhani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hardikkumar Kalubhai Vaghasiya | 06758567 | Nilrise Pharmaceuticals Private Limited , Crinova Healthcare Private Limited | Director |
| Jitendrabhai Lalajibhai Lakhani | 06747443 | Nilrise Pharmaceuticals Private Limited , Crinova Healthcare Private Limited and 2 more | Managing Director |
| Parth Hareshbhai Kalathiya | 08572199 | Crinova Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hiral Jitendrabhai Lakhani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hiral Jitendrabhai Lakhani
Hiral Jitendrabhai Lakhani currently holds 4 directorships: Nilrise Pharmaceuticals Private Limited (Director, since 09 Jan 2014, revenue ₹10.92 Cr (FY 2025)); Crinova Healthcare Private Limited (Director, since 30 Apr 2019, revenue ₹7.29 Cr (FY 2025)); Irenic Capitals Private Limited (Director, since 23 Feb 2022, revenue ₹78.5 Lakh (FY 2025)); Opurik Innovation Private Limited (Director, since 04 Jul 2024, revenue ₹4.7 Lakh (FY 2025)).
Hiral Jitendrabhai Lakhani was first appointed on 09 Jan 2014 as Director at Nilrise Pharmaceuticals Private Limited. The most recent appointment on record is 04 Jul 2024 at Opurik Innovation Private Limited.
The 4 current companies of Hiral Jitendrabhai Lakhani that report revenue have a combined latest revenue of ₹19.04 Cr: Nilrise Pharmaceuticals Private Limited ₹10.92 Cr (FY 2025); Crinova Healthcare Private Limited ₹7.29 Cr (FY 2025); Irenic Capitals Private Limited ₹78.5 Lakh (FY 2025); Opurik Innovation Private Limited ₹4.7 Lakh (FY 2025).
The current boards of Hiral Jitendrabhai Lakhani's companies include Hardikkumar Kalubhai Vaghasiya (Nilrise Pharmaceuticals Private Limited), Jitendrabhai Lalajibhai Lakhani (Nilrise Pharmaceuticals Private Limited), Parth Hareshbhai Kalathiya (Crinova Healthcare Private Limited).